Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Wybranski, Christian ^a   Zeile, Martin ^a   Löwenthal, David ^a   Fischbach, Frank ^a   Pech, Maciej ^a   Röhl, Friedrich Wilhelm ^a   Gademann, Günther ^a   Ricke, Jens ^a   Dudeck, Oliver ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; COMORBIDITY; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; FLUOROSCOPY; HUMAN; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGIST; TREATMENT RESPONSE; TUMOR VOLUME; CARCINOMA; COLORECTAL TUMOR; EVALUATION; FOLLOW UP; LIVER; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RADIATION DOSE; RADIOGRAPHY; TIME; TREATMENT OUTCOME;

BIOLOGICAL MARKER;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRACHYTHERAPY; CARCINOMA; COLORECTAL NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY DOSAGE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955139061     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-43     Document Type: Article

References (39)

1. Rappaport AM. Hepatic blood flow: morphologic aspects and physiologic regulation. Int Rev Physiol 1980, 21:1-63.
2. Kasper HU, Drebber U, Dries V, Dienes HP. [Liver metastases: incidence and histogenesis]. Z Gastroenterol 2005, 43:1149-1157.
3. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol 2005, 23:8490-8499. 10.1200/JCO.2004.00.6155, 16230676.
4. Guenette JP, Dupuy DE. Radiofrequency ablation of colorectal hepatic metastases. J Surg Oncol 2010, 102:978-987. 10.1002/jso.21658, 21166002.
5. Welsh JS, Kennedy AS, Thomadsen B. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006, 66:S62-S73.
6. Seidensticker M, Wust P, Ruhl R, Mohnike K, Pech M, Wieners G, Gademann G, Ricke J. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol 2010, 5:24. 10.1186/1748-717X-5-24, 2861689, 20334657.
7. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, Wieners G, Spors B, Werk M, Rosner C, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004, 58:1496-1505. 10.1016/j.ijrobp.2003.09.024, 15050329.
8. Ricke J, Mohnike K, Pech M, Seidensticker M, Ruhl R, Wieners G, Gaffke G, Kropf S, Felix R, Wust P. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2010, 78:479-485. 10.1016/j.ijrobp.2009.09.026, 20304566.
9. Ruhl R, Ludemann L, Czarnecka A, Streitparth F, Seidensticker M, Mohnike K, Pech M, Wust P, Ricke J. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiat Oncol 2010, 5:44. 2887889, 20507615.
10. Ricke J, Seidensticker M, Ludemann L, Pech M, Wieners G, Hengst S, Mohnike K, Cho CH, Lopez HE, Al-Abadi H, et al. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 2005, 62:776-784. 10.1016/j.ijrobp.2004.11.022, 15936559.
11. Streitparth F, Pech M, Bohmig M, Ruehl R, Peters N, Wieners G, Steinberg J, Lopez-Haenninen E, Felix R, Wust P, et al. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2006, 65:1479-1486. 10.1016/j.ijrobp.2006.02.052, 16757131.
12. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986, 161:401-407.
13. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992, 159:591-599.
14. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007, 188:1622-1635. 10.2214/AJR.06.1403, 17515386.
15. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010, 254:47-66. 10.1148/radiol.09090021, 20032142.
16. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008, 248:894-900. 10.1148/radiol.2483071407, 18710982.
17. Dudeck O, Zeile M, Wybranski C, Schulmeister A, Fischbach F, Pech M, Wieners G, Ruhl R, Grosser O, Amthauer H, et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol 2010, 20:2699-2706. 10.1007/s00330-010-1846-z, 20563725.
18. Eccles CL, Haider EA, Haider MA, Fung S, Lockwood G, Dawson LA. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations. Acta Oncol 2009, 1-10.
19. Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, Husband JE. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007, 188:1001-1008. 10.2214/AJR.06.0601, 17377036.
20. Marugami N, Tanaka T, Kitano S, Hirohashi S, Nishiofuku H, Takahashi A, Sakaguchi H, Matsuoka M, Otsuji T, Takahama J, et al. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging. Cardiovasc Intervent Radiol 2009, 32:638-646. 10.1007/s00270-009-9532-8, 19238482.
21. Schraml C, Schwenzer NF, Clasen S, Rempp HJ, Martirosian P, Claussen CD, Pereira PL. Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results. J Magn Reson Imaging 2009, 29:1308-1316. 10.1002/jmri.21770, 19418557.
22. Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, Pech M, Werk M, Rosner C, Hanninen EL, et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004, 15:1279-1286.
23. Wieners G, Pech M, Hildebrandt B, Peters N, Nicolaou A, Mohnike K, Seidensticker M, Sawicki M, Wust P, Ricke J. Phase II Feasibility Study on the Combination of Two Different Regional Treatment Approaches in Patients with Colorectal "Liver-Only" Metastases: Hepatic Interstitial Brachytherapy Plus Regional Chemotherapy. Cardiovasc Intervent Radiol 2009, 32:937-945. 10.1007/s00270-009-9597-4, 19472000.
24. Moffat BA, Chenevert TL, Lawrence TS, Meyer CR, Johnson TD, Dong Q, Tsien C, Mukherji S, Quint DJ, Gebarski SS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 2005, 102:5524-5529. 10.1073/pnas.0501532102, 555936, 15805192.
25. Moffat BA, Hall DE, Stojanovska J, McConville PJ, Moody JB, Chenevert TL, Rehemtulla A, Ross BD. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 2004, 17:249-259. 10.1007/s10334-004-0079-z, 15580371.
26. Thoeny HC, De Keyzer F, Chen F, Ni Y, Landuyt W, Verbeken EK, Bosmans H, Marchal G, Hermans R. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 2005, 234:756-764. 10.1148/radiol.2343031721, 15734932.
27. Denecker G, Vercammen D, Declercq W, Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 2001, 58:356-370. 10.1007/PL00000863, 11315185.
28. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007, 14:1237-1243. 10.1038/sj.cdd.4402148, 17431418.
29. Taatjes DJ, Sobel BE, Budd RC. Morphological and cytochemical determination of cell death by apoptosis. Histochem Cell Biol 2008, 129:33-43. 10.1007/s00418-007-0356-9, 2137940, 18000678.
30. Gromoll C, Karg A. Determination of the dose characteristics in the near area of a new type of 192Ir-HDR afterloading source with a pinpoint ionization chamber. Phys Med Biol 2002, 47:875-887.
31. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 1995, 22:209-234. 10.1118/1.597458, 7565352.
32. Denham JW, Hauer-Jensen M. The radiotherapeutic injury--a complex 'wound'. Radiother Oncol 2002, 63:129-145. 10.1016/S0167-8140(02)00060-9, 12063002.
33. Krishnan L, Krishnan EC, Jewell WR. Immediate effect of irradiation on microvasculature. Int J Radiat Oncol Biol Phys 1988, 15:147-150. 10.1016/0360-3016(88)90359-8, 3391811.
34. Baker DG, Krochak RJ. The response of the microvascular system to radiation: a review. Cancer Invest 1989, 7:287-294. 10.3109/07357908909039849, 2477120.
35. Potchen EJ, Kinzie J, Curtis C, Siegel BA, Studer RK. Effect of irradiation on tumor microvascular permeability to macromolecules. Cancer 1972, 30:639-643. 10.1002/1097-0142(197209)30:3<639::AID-CNCR2820300308>3.0.CO;2-3, 4677852.
36. Kobayashi H, Reijnders K, English S, Yordanov AT, Milenic DE, Sowers AL, Citrin D, Krishna MC, Waldmann TA, Mitchell JB, et al. Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation. Clin Cancer Res 2004, 10:7712-7720. 10.1158/1078-0432.CCR-04-1175, 15570005.
37. Latour LL, Svoboda K, Mitra PP, Sotak CH. Time-dependent diffusion of water in a biological model system. Proc Natl Acad Sci USA 1994, 91:1229-1233. 10.1073/pnas.91.4.1229, 43130, 8108392.
38. Thoeny HC, De Keyzer F, Vandecaveye V, Chen F, Sun X, Bosmans H, Hermans R, Verbeken EK, Boesch C, Marchal G, et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005, 237:492-499. 10.1148/radiol.2372041638, 16192323.
39. Jordan BF, Runquist M, Raghunand N, Baker A, Williams R, Kirkpatrick L, Powis G, Gillies RJ. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia 2005, 7:475-485. 10.1593/neo.04628, 1501160, 15967100.